Influence of the Use of Specific Nutritional Formulas on Time in Range in Patients With Type 2 Diabetes
- Sponsor
- Hospital Universitario San Ignacio
- Study ID
- NCT07666581
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Obesity & Overweight
- Time in Range
- Type 2 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Glucerna — DIETARY_SUPPLEMENTA calorie-restricted diet plan is prescribed (see Table 1). In this group, Glucerna will be prescribed for breakfast and snacks as part of the total calories calculated for each patient's meal plan. Dietary plan prescription of 1200 to 1500 kcal for women and 1500 to 1800 kcal for men.
- Caloric restriction — OTHERDietary plan prescription of 1200 to 1500 kcal for women and 1500 to 1800 kcal for men.
Study Details
Who can participate? Individuals may be eligible to join this study if they meet the following criteria: * Are 18 years or older. * Have Type 2 diabetes with an A1c level higher than 7%. * Have a Body Mass Index (BMI) between 27 and 35 (considered overweight or Class 1 obesity). * Have used a continuous glucose monitor (CGM) successfully in the past. How the study works: If eligible individuals decide to join and sign the consent form, a computer will randomly assign them into one of two groups: The Formula Group: Participants will replace their usual breakfast and one snack with a specific diabetes nutritional drink (Glucerna®). The Standard Diet Group: Participants will follow a standard low-calorie meal plan without using the nutritional drink. Both groups will aim for a specific daily calorie goal (1,200-1,500 for women; 1,500-1,800 for men) and will receive expert nutritional counseling. Monitoring and Follow-up Over the course of 3 months, close contact will be maintained to support participants: Every 2 weeks: A nutrition expert will call participants to check on their diet and help with their glucose monitor. Every month: Participants will meet with the study team in person to review glucose monitor data. Tests: At the start and end of the study, weight, body composition, blood sugar (A1c), and cholesterol levels will be measured to see how the plans worked.
Key Dates
- First listed
- Jun 24, 2026
- Start date
- Aug 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Apr 30, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 198 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: GlucernaA calorie-restricted diet plan is prescribed (see Table 1). In this group, Glucerna will be prescribed for breakfast and snacks as part of the total calories calculated for each patient's meal plan.
- Placebo Comparator: PlaceboDietary plan prescription of 1200 to 1500 kcal for women and 1500 to 1800 kcal for men.
Primary Outcome Measure
Time in range [ Time Frame: 3 months ]
Central Contacts
- Ana M Gómez - Medina, Endocrinologyst+57 601 5946161
- Diana C Henao-Carrillo, Endocrinologyst+57 601 5946161
Find similar trials
Related Studies
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older AdultsRecruiting · AdventHealth Translational Research Institute · Orlando, Florida
- Sleep and Glycemic Control in Type 2 Diabetes AdolescentsRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Brown Adipose Tissue Activation by Spinal Cord StimulationRecruiting · Oregon Health and Science University · Portland, Oregon
- Mechanisms of Fatigability With DiabetesRecruiting · University of Michigan · Ann Arbor, Michigan